| abstract |
It refers to carboxamide derivatives, a process for their preparation, pharmaceutical compositions containing them, and their use as mGluR1 enhancers in the treatment and prevention of neurological diseases and disorders. Claim 1: A compound of general formula (1), in which: one of R1 and R2 means trifluoromethyl and the other means hydrogen; R3, R3 'means independently of each other, hydrogen or halogen; as well as its pharmaceutically acceptable salts. |